Meloxicam G.L. (Meloxicam)

Meloxicam blocks cyclooxygenase enzymes, especially COX‑2, which are responsible for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain, and fever in the affected tissues.

The exact dose of meloxicam is determined by the prescribing clinician based on the patient’s condition, age, renal function and other factors. Typical adult regimens range from low to moderate daily amounts, but the prescriber sets the final dosage and schedule.

Safety data for meloxicam in pregnancy and lactation are limited, and the drug is generally classified as contraindicated or to be used only if the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam has a longer half‑life than many traditional NSAIDs, allowing once‑daily dosing for many patients. It shows greater selectivity for COX‑2, which may reduce gastrointestinal side effects compared with non‑selective agents, though cardiovascular and renal risks remain similar.

Store Meloxicam G.L. at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Meloxicam G.L. is taken orally, usually as a whole tablet or capsule swallowed with a glass of water. It can be taken with or without food, but taking it with food may lessen stomach upset.

Serious adverse events include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, acute kidney injury, elevated liver enzymes, and increased risk of cardiovascular events like heart attack or stroke. Patients should seek immediate medical attention if they notice signs of these conditions.

Meloxicam should be avoided in individuals with known hypersensitivity to the drug, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, uncontrolled hypertension, and in patients who are pregnant unless clearly indicated. It is also contraindicated in those taking certain anticoagulants without close monitoring.